H. Tinteren

A. Aalbers, H. Tinteren, W. Prevoo, 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Randomized T rial o f C ytoreduction a nd H yperthermic Intraperitoneal C hemotherapy V ersus S ystemic C hemotherapy and P alliative S urgery i n P atients W ith P eritoneal Carcinomatosis o f C olorectal C ancer

H. Tinteren, H. Boot, E. Bree, 2003 .

Randomized Tria l o f Cytoreduct ion and Hyperthermic Intraper i toneal Chemotherapy Versus Systemic Chemotherapy and Pal l ia t i ve Surgery in Pat ients With Per i toneal Carc inomatos is of Colorecta l Cancer

H. Tinteren, H. Boot, F. Zoetmulder, 2003 .

Final results and subgroup analyses of the phase 3 CAIRO3 study: Maintenance treatment with capecitabine + bevacizumab versus observation after induction treatment with chemotherapy + bevacizumab in metastatic colorectal cancer (mCRC).

C. Punt, M. Koopman, A. May, 2014 .

Randomized controlled trial (RCT) to evaluate the cost-effectiveness of positron emission tomography (PET) added to conventional diagnostic strategies in non-small cell lung cancer (NSCLC)

O. Hoekstra, E. Smit, H. Tinteren, 2000 .

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial

M. Boers, O. Hoekstra, E. Smit, 2002, The Lancet.

The implementation of PET in non-small-cell lung cancer in the Netherlands.

H. Tinteren, 2006 .

The need for Health Technology Assessments of PET

M. Boers, O. Hoekstra, H. Tinteren, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Trends in treatment and survival for advanced laryngeal cancer: A 20‐year population‐based study in The Netherlands

F. Hilgers, H. Tinteren, M. Brekel, 2016, Head & neck.

Activation Carcinoma Requires In Vivo T Cell TCR Gene Therapy of Spontaneous Prostate

H. Tinteren, T. Schell, S. Tevethia, 2008 .

Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial

K. Pritchard-Jones, I. Leuschner, L. Boccon-Gibod, 2015, The Lancet.

Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

C. Faivre-Finn, S. Senan, B. Slotman, 2015, The Lancet.

Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments

A. Oudenaarden, A. van Oudenaarden, H. Horlings, 2021, Clinical Cancer Research.

International Multicenter Randomized Study on Thoracic Radiation Therapy (RT) in Extensive Stage Small Cell Lung Cancer (ES-SCLC): Patterns of Disease Recurrence

C. Faivre-Finn, S. Senan, J. Praag, 2014 .

Randomized trial on thoracic radiotherapy (TRT) in extensive-stage small cell lung cancer.

C. Faivre-Finn, S. Senan, B. Slotman, 2014 .

Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy

H. Tinteren, B. Ehmer, N. Reed, 1998, Medical oncology.

Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer (mCRC): The phase III CAIRO3 study of the Dutch Colorectal Cancer Group (DCCG).

O. Dalesio, C. Punt, M. Koopman, 2013 .

Cytoreduction and hyoerthermic intraperitoneal chemotherapy in peritoneal carcinomastosis of colorectal origin

H. Tinteren, S. Ruth, J. Verwaai, 2007 .

A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: First results from the CRITICS study.

H. Putter, N. Aaronson, K. Sikorska, 2016 .

MA 17.10 Toxicity Results from the Randomized Phase III NVALT-11 Study of Prophylactic Cranial Irradiation vs. Observation in Stage III NSCLC

H. Groen, E. Smit, A. Dingemans, 2017 .

Prophylactic cranial irradiation (PCI) versus observation in radically treated stage III non-small cell lung cancer (NSCLC): A randomized phase III NVALT11 study.

H. Groen, E. Smit, A. Dingemans, 2017 .

Chemotherapy as primary treatment for brain metastases from breast cancer: analysis of 115 one-year survivors

J. Baars, S. Linn, H. Tinteren, 2012, Journal of Cancer Research and Clinical Oncology.

Dynamic Sentinel Node Biopsy in Penile Carcinoma: Evaluation of 10 Years Experience

W. Meinhardt, H. van Tinteren, S. Horenblas, 2006 .

Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours

S. Muller, F. Hilgers, A. Balm, 1996, European Journal of Nuclear Medicine.

Pediatric renal tumor epidemiology: Global perspectives, progress, and challenges

H. Tinteren, C. Duncan, P. Ehrlich, 2022, Pediatric blood & cancer.

Modulation of 5-fluorouracil in the adjuvant setting: high-dose, low-dose or no-dose leucovorin?

H. Tinteren, B. Taal, A. Cats, 2006, Nature Clinical Practice Oncology.

8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

S. Bruin, H. Tinteren, H. Boot, 2008, Annals of Surgical Oncology.

Toxicity of cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapy

H. Tinteren, F. Zoetmulder, V. Verwaal, 2004, Journal of surgical oncology.

Technetium-99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer

H. Tinteren, E. A. Royen, C. Hoefnagel, 1994, European Journal of Nuclear Medicine.

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

A. Broeks, T. Schumacher, K. Sikorska, 2018, Nature Medicine.

Risk of endometrial cancer after tamoxifen treatment of breast cancer

J. Willem, L. Schouten, F. V. van Leeuwen, 1994, The Lancet.

Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial

N Graf, H. Tinteren, N. Graf, 2004, The Lancet.

Phase III study comparing cyclophosphamide, doxorubicin, and etoposide (CDE) to carboplatin and paclitaxel (CP) in patients (pts) with extensive disease small cell lung cancer (ED SCLC).

E. Smit, H. Tinteren, H. Groen, 2005 .

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma

Z. Szallasi, T. Schumacher, J. Larkin, 2014, Cancer Immunology, Immunotherapy.

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

Annuska M. Glas, A. Glas, S. Rodenhuis, 2010, Breast Cancer Research and Treatment.

Reasons for Undertreatment with Oral Anticoagulants in Frail Geriatric Outpatients with Atrial Fibrillation

J. Beijnen, H. Tinteren, L. Tulner, 2010, Drugs & aging.

Predicting Early Chemotherapy Response with Technetium-99m Methoxyisobutylisonitrile SPECT/CT in Advanced Non-Small Cell Lung Cancer

M. Verheij, H. Tinteren, S. Burgers, 2010, Molecular Imaging and Biology.

Is the absolute blastema volume after preoperative chemotherapy in nephroblastoma relevant for prognosis? [Abstract]

K. Pritchard-Jones, I. Leuschner, H. Tinteren, 2011 .

Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP–RTSG 2016 protocol

C. Rübe, K. Pritchard-Jones, I. Leuschner, 2018, Nature Reviews Urology.

Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.

K. Pritchard-Jones, H. Tinteren, J. Brok, 2018, The Lancet. Oncology.

Recurrences after Peritoneal Carcinomatosis of Colorectal Origin Treated by Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Location, Treatment, and Outcome

H. Tinteren, H. Boot, F. Zoetmulder, 2004, Annals of Surgical Oncology.

Acceptance and long-term compliance of nCPAP in obstructive sleep apnea

H. Tinteren, N. Vries, W. Richard, 2007, European Archives of Oto-Rhino-Laryngology.

Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma

Z. Szallasi, T. Schumacher, J. Larkin, 2013 .

UPPP combined with radiofrequency thermotherapy of the tongue base for the treatment of obstructive sleep apnea syndrome

H. Tinteren, N. Vries, W. Richard, 2008, European Archives of Oto-Rhino-Laryngology.

Sleep endoscopy versus modified Mallampati score in sleep apnea and snoring.

H. Tinteren, N. Vries, C. Herder, 2005 .

Hyoidthyroidpexia: a surgical treatment for sleep apnea syndrome.

H. Tinteren, N. Vries, C. Herder, 2005 .

One stage multilevel surgery (uvulopalatopharyngoplasty, hyoid suspension, radiofrequent ablation of the tongue base with/without genioglossus advancement), in obstructive sleep apnea syndrome

H. Tinteren, N. Vries, W. Richard, 2007, European Archives of Oto-Rhino-Laryngology.

Bipolar radiofrequency induced thermotherapy of the tongue base: its complications, acceptance and effectiveness under local anesthesia

H. Tinteren, N. Vries, D. Kox, 2006, European Archives of Oto-Rhino-Laryngology and Head & Neck.

UvA-DARE ( Digital Academic Repository ) Who needs adjuvant systemic treatment ? Predicting prognosis in node-negative breast cancer ; from bench to bedside

S. Linn, D. Nuyten, J. Wesseling, 2009 .

Complications of hyoid suspension in the treatment of obstructive sleep apnea syndrome

H. Tinteren, N. Vries, W. Richard, 2011, European Archives of Oto-Rhino-Laryngology.

Radiation therapy in early stage Hodgkin's disease: long-term results and adverse effects.

B. Slotman, J. Zijlstra, H. Tinteren, 2002, The hematology journal : the official journal of the European Haematology Association.

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

C. Punt, M. Koopman, A. May, 2015, The Lancet.

Neuro-cognitive (HVLT-R total recall) functioning in localized vs. metastatic small-cell lung cancer with or without hippocampus sparing PCI: Results from a phase III trial

D. Ruysscher, K. Sikorska, E. Dieleman, 2019, Lung cancer.

OC-0503 Phase III trial of Prophylactic Cranial Irradiation with or without Hippocampus Avoidance in SCLC

K. Sikorska, S. Deprez, J. Belderbos, 2019, Radiotherapy and Oncology.

Radiotherapy for extensive stage small-cell lung cancer – Authors' reply

C. Faivre-Finn, S. Senan, B. Slotman, 2015, The Lancet.

Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial.

H. Bartelink, L. Collette, E. van Werkhoven, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Randomized trial of chemoprevention with vitamin A and N-acetylcysteine in patients with cancer of the upper and lower airways: the EUROSCAN study

O. Dalesio, U. Pastorino, H. Tinteren, 1999 .

Evaluating Positron Emission Tomography in Non-small cell Lung Cancer: Moving Beyond Accuracy to Outcome

M. Boers, O. Hoekstra, H. Tinteren, 2008 .

Do we need randomised trials to evaluate diagnostic procedures?

M. Boers, O. Hoekstra, H. Tinteren, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Feasibility and toxicity of neoadjuvant nivolumab with or without ipilimumab prior to extensive (salvage) surgery in patients with advanced head and neck cancer (the IMCISION trial, NCT03003637).

T. Schumacher, L. Smit, C. Blank, 2019, Journal of Clinical Oncology.

Pediatric renal tumor epidemiology: Global perspectives, progress, and challenges

H. Tinteren, C. Duncan, P. Ehrlich, 2023, Pediatric blood & cancer.

Brain metastases in patients with pelvic or abdominal malignancy do not prevail in the posterior fossa: a retrospective study

H. Tinteren, W. Boogerd, D. Brandsma, 2009, Journal of Neurology.

Patients with penile cancer and the risk of (pre)malignant cervical lesions in female partners: a retrospective cohort analysis

G. Kenter, S. Horenblas, H. Tinteren, 2013, BJU international.

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer : Update of the Dutch randomized

S. Rodenhuis, M. Nooij, D. Richel, 2005 .

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial

S. Rodenhuis, M. Nooij, E. Wall, 2005, Breast Cancer Research.

10 years follow up of the RASTER study: implementing a genomic signature in daily practice

E. Rutgers, S. Linn, J. Wesseling, 2017 .

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

Bingshu E. Chen, R. Gray, P. Lønning, 2023, The Lancet.

Centralization of Upper Gastrointestinal Cancer Care Should be Dictated by Quality of Care

H. Tinteren, J. Sandick, W. T. Te Riele, 2017, Annals of Surgical Oncology.

Combining Brentuximab Vedotin with DHAP as Salvage Treatment in Relapsed/Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE study

M. Kersten, A. Hagenbeek, J. Zijlstra, 2018, Blood.

How to evaluate quality for Thoracic Lung Cancer Surgery: A ‘’textbook outcome’’

P. Baas, H. Klomp, J. Burgers, 2015 .

Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04).

S. Linn, M. Kok, J. Wesseling, 2018, European journal of cancer.

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.

C. Seynaeve, J. Nortier, H. van Tinteren, 2014, Breast.

Randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in completely resected non-small cell lung cancer patients: The NVALT-8 study.

H. Groen, E. Smit, F. Schramel, 2016 .

Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.

G. Giaccone, E. Smit, C. Ferreira, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy

M. J. van de Vijver, S. Rodenhuis, P. Kristel, 2006, British Journal of Cancer.

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups.

O. Dalesio, U. Pastorino, N. de Vries, 2000, Journal of the National Cancer Institute.

Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer

A. Harris, A. Shvarts, P. Groep, 2005, Journal of Clinical Pathology.

Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy

H. van Tinteren, H. Tinteren, F. Zoetmulder, 2004, The British journal of surgery.

Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlotinib and gefitinib treatment

H. Klomp, N. van Zandwijk, H. van Tinteren, 2010, Ecancermedicalscience.

A comparison of physical examination and imaging in determining the extent of primary penile carcinoma

M. Gallee, H. van Tinteren, S. Horenblas, 2003, BJU international.

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

H. van Tinteren, H. Tinteren, J. Wagstaff, 1993, British Journal of Cancer.

Surgical treatment of locally recurrent rectal cancer.

H. van Tinteren, H. Tinteren, F. Zoetmulder, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment

P. V. van Diest, R. Michalides, A. Balkenende, 2002, British Journal of Cancer.

Incidence and outcomes of patients with late recurrence of Wilms' tumor

K. Pritchard-Jones, J. Dome, H. van Tinteren, 2013, Pediatric blood & cancer.

3-year relapse-free survival (RFS), overall survival (OS) and long-term toxicity of (neo)adjuvant ipilimumab (IPI) + nivolumab (NIVO) in macroscopic stage III melanoma (OpACIN trial)

T. Schumacher, K. Sikorska, C. Blank, 2019, Annals of Oncology.

Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy.

M. Gallee, H. van Tinteren, S. Horenblas, 2003, The Journal of urology.

Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.

E. Jassem, N. van Zandwijk, W. Mooi, 1992, Seminars in oncology.

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a multicentre, open-label, randomised phase 2 trial.

A. Jager, S. Linn, H. van Tinteren, 2014, European journal of cancer.

A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.

J. Peterse, R. Michalides, E. Wientjens, 1996, British Journal of Cancer.

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

W. V. van Harten, L. J. Veer, S. Linn, 2014, Breast Cancer Research and Treatment.

Long-term impact of the 70-gene signature on breast cancer outcome

M. J. van de Vijver, R. Bernards, L. J. Veer, 2014, Breast Cancer Research and Treatment.

Prospective cost-effectiveness analysis of genomic profiling in breast cancer.

W. V. van Harten, S. Linn, J. Bueno-de-Mesquita, 2013, European journal of cancer.

The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment.

M. J. van de Vijver, S. Linn, D. Nuyten, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.

J. Schornagel, W. Meinhardt, H. van Tinteren, 2005, The Journal of urology.

Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system.

H. van Tinteren, S. Horenblas, H. Tinteren, 1994, The Journal of urology.

Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma.

E. Jassem, N. van Zandwijk, H. van Tinteren, 1990, European journal of cancer.

Systematic overview (metaanalysis) of all randomized trials of treatment of prostate cancer

O. Dalesio, H. van Tinteren, H. Tinteren, 1993, Cancer.

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

J. Schellens, J. Beijnen, J. Schellens, 2014, British Journal of Cancer.

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

J. V. van Meerbeeck, S. Senan, P. Baas, 2006, British Journal of Cancer.

A Phase 1 Comparative Pharmacokinetic and Cardiac Safety Study of Two Intravenous Formulations of CO‐101 in Patients With Advanced Solid Tumors

J. Schellens, H. Rosing, J. Beijnen, 2013, Journal of clinical pharmacology.

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.

M. J. van de Vijver, J. Peterse, P. Devilee, 1992, Cancer research.

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG.

C. Seynaeve, J. Nortier, H. van Tinteren, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Patient selection for high-dose chemotherapy in stage II and IV breast cancer

H. Tinteren, E. Rutgers, J. Peterse, 2004 .

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

H. van Tinteren, H. Tinteren, P. Huijgens, 1999, Journal of clinical pathology.

The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool

A. Verbeek, G. D. den Heeten, H. Zonderland, 2012, European Radiology.

Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer

J. V. van Sandick, M. V. van Velthuysen, H. van Tinteren, 2010, The British journal of surgery.

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

A. Broeks, T. Schumacher, K. Sikorska, 2018, Nature Medicine.

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging.

O. Hoekstra, E. Smit, A. Dingemans, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group.

N. Vogelzang, H. van Tinteren, M. Soloway, 1992, The Journal of urology.

Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study

E. Strengman, M. Koopman, H. van Tinteren, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer.

M. V. van Oijen, C. Punt, M. Koopman, 2017, European journal of cancer.

A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer

A. Aalbers, H. Tinteren, W. Prevoo, 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

T. Wiggers, H. van Tinteren, H. Tinteren, 2001, British Journal of Cancer.

Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.

N Graf, R. Pieters, I. Leuschner, 2013, European journal of cancer.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)

M. Lahaye, J. V. van Sandick, A. Aalbers, 2019, BMC Cancer.

A. Wymenga, H. Tinteren, M. Hamaker, 2014, Breast.

Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001

K. Pritchard-Jones, H. van Tinteren, H. Tinteren, 2019, PloS one.

Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patients.

P. Baas, N. van Zandwijk, H. van Tinteren, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

M. J. van de Vijver, S. Rodenhuis, M. Hauptmann, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Follow-up after cystectomy: regularly scheduled, risk adjusted, or symptom guided? Patterns of recurrence, relapse presentation, and survival after cystectomy.

H. G. van der Poel, W. Meinhardt, H. van Tinteren, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.

G. Giaccone, E. Smit, C. Ferreira, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

UvA-DARE Effectiveness of an 18F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial